HIV Primer for the Non-Infectious Disease Clinicians
Sponsored by:
The University of Cincinnati and the University of Cincinnati Local Performance Site of the Pennsylvania/MidAtlantic AIDS Education & Training Center
March 19, 2010
12:00 pm– 1:30PM
Location:
Kingsgate Marriott
151 Goodman Drive
Cincinnati, OH 45219
Contact:
Jameika A. Sampson, MPH
513-584-1488
sampsojk@uc.edu
Presenter:
Dr. Pamposh Kaul, Assistant Professor Infectious Disease, University of Cincinnati College of Medicine, Clinical Director PAMAAETC UC Local Performance Site
Target Audience:
Non-Infections Disease Clinicians—MDs, RNs, NPs, PAs, Pharmacists, Dentists, Social Workers
Course Objectives:
- Define diagnostic and clinical monitoring tests commonly used in HIV care
- Recognize HIV related opportunistic infections that typically pre-sent during medical crisis periods.
- Explain the importance of adherence to antiretroviral therapy in inpatient and outpatient settings.
- Identify resources to assist in providing optimal and appropriate care to hospitalized HIV-infected persons.
For additional information on the continuing education, program agenda and to access registration information, click here
Deadline for registration is March 15, 2010
Participants must attend the entire program and complete an evaluation form in order to receive CE credit.
Updated Guidelines for the Treatment of HIV/AIDS
The U.S. Department of Health and Human Services (HHS) issues guidelines to help doctors treat people with HIV in the United States. Separate guidelines have been developed for:
The guidelines are written in sophisticated medical language and may be challenging for the general public to read and understand. "HIV and Its Treatment: What You Should Know" is a series of easy-to-read fact sheets based on the Federal guidelines. These fact sheets can help you understand the recommendations found in the guidelines.
Who writes the guidelines? The guidelines are written, reviewed, and updated by panels of HIV experts from across the country. Panel members include physicians, pharmacists, researchers, and HIV treatment advocates.
What information is used in developing the guidelines? The panels of HIV experts study drug information submitted to the U.S. Food and Drug Administration (FDA), as well as research findings presented at conferences and published in professional journals. Often new information comes from clinical trials testing the safety and effectiveness of different treatments. Members of the guidelines panels also use their own clinical experience to make the recommendations found in the treatment guidelines.
Ohio Department of Health HIV Care Services Section Fact Sheet: HIV and Co-infections
People living with HIV/AIDS (PLWHA) may also become infected with other infectious diseases such as hepatitis B (HBV), hepatitis C (HCV), chlamydia, gonorrhea, and syphilis. These diseases represent a serious health risk to those infected, especially for those whose immune systems are already compromised by HIV.
According to 2007 Ohio statistics, of the 11,466,917 people living in Ohio, 15,413 were reported to have HIV, 11,319 were reported to have HCV, 45,879 were reported to have Chlamydia, 20,034 were reported to have Gonorrhea, and 554 were reported to have Syphilis. Those infected may have one or a combination of more than one of these diseases.
To view the Fact Sheet on HIV and Co-infections, click here
To view the Ohio Department of Health Fact Sheet on HIV & Oral Health, click here
To view the Ohio Department of Health Fact Sheet on Vaccinations for People Living with HIV/AIDS, click here
Participants Wanted for an HIV Research Project
This study is designed to help gay and bisexual men improve their HIV- disclosure skills and reduce their sexual risk behaviors. Dr. Julianne Serovich, Professor and Chair in the Department of Human Development and Family Science at The Ohio State University, developed the study in conjunction with other HIV researchers, prevention specialists, and HIV-positive men who have sex with men (MSM), and is now recruiting research participants to test the program’s effectiveness.
Dr. Serovich is interested in recruiting HIV-positive gay and bisexual men, who are 18 years old or older, currently sexually active, and are willing to participate in 5 project sessions and 2 additional assessment sessions over a one year-period. Each session is expected to last approximately 1 ½ hours, and participants could earn a total of $235.
Participants are randomly assigned to one of two conditions: a disclosure program or a comparable risk reduction program.
Participation is voluntary and all information associated with this study will remain strictly confidential. If you have questions or would like to discuss eligibility, please contact the project office at (614) 688-4168. Minorities are especially encouraged to participate.
|
